Holen Sie sich die Stockscreener-App
7.40
2.89%
-0.22
Biocryst Pharmaceuticals Inc Aktie (BCRX) Neueste Nachrichten
Published on: 2026-01-10 14:45:46 - ulpravda.ru
FDA approves seven NMEs in December - BioCentury
BioCryst Pharmaceuticals raises US price of Orladeyo to $48,487.92 per pack - Investing.com Nigeria
BioCryst Pharmaceuticals raises US price of Orladeyo to $48,487.92 per pack By Investing.com - Investing.com South Africa
BioCryst Raises Price of Key ORLADEYO Treatment - TipRanks
Is BioCryst Pharmaceuticals Inc. stock oversold or undervalued2025 Trading Recap & AI Forecasted Entry and Exit Points - ulpravda.ru
How BioCryst Pharmaceuticals Inc. stock reacts to bond yieldsJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - ulpravda.ru
Will BioCryst Pharmaceuticals Inc. stock benefit from upcoming earnings reportsGap Down & Free Verified High Yield Trade Plans - ulpravda.ru
CEO Moves: Will BioCryst Pharmaceuticals Inc. stock deliver long term returnsPortfolio Update Report & Expert Verified Movement Alerts - ulpravda.ru
A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Undervalued Narrative Gains Traction - Yahoo Finance
RBC Cuts Price Target on BioCryst Pharmaceuticals to $14 From $15, Keeps Outperform Rating - MarketScreener
Astria Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc.ATXS - The Malaysian Reserve
BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A Look At 178% Potential Upside - DirectorsTalk Interviews
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Liquidity Mapping Around (BCRX) Price Events - Stock Traders Daily
Will BioCryst Pharmaceuticals Inc. stock beat EPS estimatesRisk Management Strategies & Invest Smarter With Signals - bollywoodhelpline.com
Astria faces shareholder lawsuits over planned BioCryst merger - MSN
Charlie Gayer to be BioCryst CEO effective January 1 - The Pharma Letter
BioCryst Pharmaceuticals Face Numerous Important Catalysts in 2026, Wedbush Says - marketscreener.com
Rice Hall James & Associates LLC Sells 179,891 Shares of BioCryst Pharmaceuticals, Inc. $BCRX - MarketBeat
Price-Driven Insight from (BCRX) for Rule-Based Strategy - Stock Traders Daily
Trade Report: Why BioCryst Pharmaceuticals Inc. stock is in analyst buy zone2025 Market Sentiment & Advanced Technical Signal Analysis - moha.gov.vn
Astria Therapeutics IncComplaints filed against Astria in New York Supreme CourtSEC filing - marketscreener.com
Astria Faces Shareholder Lawsuits Over Planned BioCryst Merger - TipRanks
Alane Barnes Sells 21,773 Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock - MarketBeat
Astria Therapeutics Merger with BioCryst Pharmaceuticals - TradingView — Track All Markets
1-year trial data: Orladeyo cuts swelling attacks in young children - Angioedema News
H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30 - Insider Monkey
Is BioCryst Pharmaceuticals Inc. stock supported by strong fundamentalsBond Market & Short-Term High Return Strategies - Улправда
12 Small Cap Stocks to Buy with Huge Upside Potential - Insider Monkey
Assenagon Asset Management S.A. Lowers Holdings in BioCryst Pharmaceuticals, Inc. $BCRX - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-ATXS, MBCN, FMNB, and SEMR - The Malaysian Reserve
Published on: 2025-12-19 20:19:26 - ulpravda.ru
Will BioCryst Pharmaceuticals Inc. stock deliver strong dividend growthGold Moves & Free Community Supported Trade Ideas - DonanımHaber
What is the fair value of BioCryst Pharmaceuticals Inc. stock now2025 Support & Resistance & Safe Capital Growth Stock Tips - DonanımHaber
ETF Watch: What is the fair value of BioCryst Pharmaceuticals Inc. stock now2025 Support & Resistance & Safe Capital Growth Stock Tips - DonanımHaber
EDGAR Filing Documents for 0001140361-25-046040 - SEC.gov
Astria Therapeutics (NASDAQ: ATXS) details terms of BioCryst merger and special vote - Stock Titan
BioCryst Pharmaceuticals (BCRX) details cash and stock deal to acquire Astria - Stock Titan
Why BioCryst Pharmaceuticals Inc. stock is in analyst buy zone2025 Key Lessons & Risk Controlled Swing Alerts - Улправда
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - MarketBeat
BioCryst Pharmaceuticals (BCRX) officer reports 8,181-share tax withholding - Stock Titan
Q4 Earnings Estimate for BCRX Issued By HC Wainwright - MarketBeat
BioCryst Pharmaceuticals (BCRX) CLO reports tax withholding and share sale - Stock Titan
CEO Stonehouse Surrenders 27,368 Of BioCryst Pharmaceuticals Inc [BCRX] - TradingView — Track All Markets
BioCryst Pharmaceuticals (NASDAQ: BCRX) CEO reports tax share withholding - Stock Titan
BioCryst Pharma stock price target raised to $32 by H.C. Wainwright - Investing.com Canada
HC Wainwright Has Bullish Estimate for BCRX FY2025 Earnings - MarketBeat
Why are retail traders going gaga over BioCryst Pharma stock today? - MSN
Does The Market Misread BioCryst Pharmaceuticals After DCF Upside And Low Sales Multiple In 2025? - Yahoo Finance
0.37%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):